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ABSTRACT 
Background 
The last decade has seen a drive towards non-medical prescribing in the United 
Kingdom (UK). However, there is a dearth of any published literature on applying 
the principles of service redesign to support pharmacist prescribing in any sphere 
of practice. 
Objective 
To develop consensus guidance to facilitate service redesign around pharmacist 
prescribing.  
Setting 
UK hospital practice. 
Method 
The Delphi technique was used to measure consensus of a panel of expert opinion 
holders in Scotland. Individuals with key strategic and operational roles in 
implementing initiatives of pharmacy practice and medicines management were 
recruited as experts.  An electronic questionnaire consisting of 30 statements 
related to pharmacist prescribing service redesign was developed. These were 
presented as 5-point Likert scales with illustrative quotes. 
Main Outcome Measures 
Consensus, defined as 70% of panel members agreeing (ranked strongly 
agree/agree) with each statement. 
Results  
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Responses were obtained from 35/40 (87.5%) experts in round one and 29 
(72.5%) in round two. Consensus in round one was achieved for 27/30 of 
statements relating to aspects of generic ‘service development’ (e.g. succession 
planning, multidisciplinary working, quality evaluation, practice development and 
outcome measures) and ‘pharmacist prescribing role development’ (e.g. 
education and future orientation of service). Issues of disagreement were around 
targeting of pharmacist prescribing to clinical specialities and financial 
remuneration for prescribing in the hospital setting.  
Conclusion 
Consensus guidance has been developed to facilitate service redesign around 
hospital pharmacist prescribing.  
 
Impact of Findings on Practice Statements 
• Consensus obtained from expert opinion holders relating to statements 
around aspects of generic ‘service development’ of pharmacist prescribing 
in secondary care (e.g. succession planning, multidisciplinary working, 
quality evaluation, practice development and outcome measures) and 
‘pharmacist prescribing role development’ (e.g. education and future 
orientation of service) inform the implementation of pharmacist 
prescribing services in hospital practice 
• The lack of consensus around issues of pharmacist prescribing being a 
general or specialist role, and remuneration of pharmacist prescribers 
indicate need for further widespread discussion.  
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INTRODUCTION  
The last decade has seen a drive towards non-medical [non-physicians such as 
pharmacists and nurses] prescribing in the UK with legislation to allow 
implementation of supplementary prescribing (SP) and independent prescribing 
(IP). There are around 24,000 nurse independent prescribers, 2,500 pharmacist 
supplementary/independent prescribers and several hundred allied health 
professional (e.g. optometrists) supplementary prescribers in the UK [1]. These 
prescribers are practising in the management of chronic diseases (e.g. 
cardiovascular, respiratory and endocrine) or in the management of acute 
episodes of infection and minor ailments [2]. 
While pharmacist supplementary prescribers can manage any diagnosed condition 
and prescribe any drug as defined by a patient-specific clinical management plan, 
independent pharmacist prescribers can prescribe any drug for both diagnosed 
and undiagnosed medical conditions [3-5]. SP and IP aim to: improve patient 
care; increase patient choice; make full use of the skills of health professionals; 
and contribute to the more flexible team working across the National Health 
Service (NHS) [1,3].  
Training programmes for pharmacist prescribers are provided by higher education 
institutions and are defined and accredited by the General Pharmaceutical 
Council. Programmes comprise two components: a university component 
equivalent to 26 days of full-time education; and a period of learning in practice 
of a minimum of 12 days under the supervision of a designated physician [6]. 
Successful completion of the IP course permits practise of both SP and IP. 
Research conducted from the perspectives of pharmacist prescribers, physicians, 
patients who have experienced the services, other health professionals and the 
general public have largely generated positive findings [7-15]. However, many of 
these studies are limited by small sample sizes; sampling, recruitment, response 
and recall biases; and notably few have focused on secondary care. Given the 
scale of prescribing errors committed by junior doctors in hospital settings of 
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between 4.2 to 82% of patients or prescription charts [16], there is vast potential 
for pharmacist prescribing to impact patient care in terms of safe and effective 
prescribing and use of medicines. However, implementation of hospital based 
pharmacist prescribing requires clear and systematic planning, with defined and 
well communicated roles and responsibilities to ensure that services are 
sustainable. Several authors have specifically commented on the lack of clear 
strategic direction in hospital based pharmacist prescribing service developments 
[2,6,7,12-14]. 
There is a dearth of published research literature on applying principles of service 
redesign to support key innovations, such as pharmacist prescribing, in any 
sphere of hospital practice. The principles of service redesign have been 
articulated by the NHS in Scotland. Key points are that redesign should: be 
patient focused; involve all stakeholders; promote effective team working; and 
focus on improving the patient's experience and outcomes of care [17].  
Consensus research methods are particularly suited to development of policies, 
quality indicators and professional norms and hence are highly appropriate to 
areas of service redesign [18]. These methods systematically gather expert 
opinion usually in areas where there is a lack of or incomplete evidence. There 
are several reports of the application of consensus approaches to non-prescribing 
related developments in pharmacy practice. These relate to: synthesis of criteria 
to assess the quality of documentation associated with the Medicines Utilisation 
Review in England [19]; to agree the definition of ‘dispensing error’ within 
community pharmacy [20]; to develop competencies associated with training 
needs in public health for Scottish community pharmacists [21]; and to generate 
a model of pharmaceutical care for the patient with type 2 diabetes mellitus in 
primary care [22]. In the USA, consensus studies have assisted the development 
of: components required for training of community pharmacists [23]; agreeing 
present and future challenges facing pharmacy executive [24,25]; and 
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formulating a list of clinically significant drug-drug interactions between oral 
anticancer drugs and concomitant therapies [26]. 
 
AIM OF THE STUDY 
The aim of this research was to develop consensus guidance to facilitate strategic 
planning and service redesign around pharmacist prescribing implementation in 
UK hospital practice.  
 
ETHICAL APPROVAL 
The North East of Scotland Research Ethics Committee advised that there was no 
need for NHS ethical review. The study was approved by the Ethical Review Panel 
of the School of Pharmacy and Life Sciences at Robert Gordon University, 
Aberdeen, UK.  
 
METHOD  
Typical features of a Delphi approach are: an expert panel; a series of rounds in 
which data are collected, analysed and fed back; and opportunity for experts to 
use this feedback to reflect and revise their judgments. The Delphi approach was 
selected over other consensus methods, such as the nominal group technique, as 
it allowed data collection at a distance, avoiding the need for experts to meet 
face-to-face [27]. 
Expert opinion holders  
Individuals in Scotland with key strategic and operational roles in implementing 
initiatives of pharmacy practice and medicines management in hospital were 
invited to be members of the expert panel. An introductory email was sent to all 
14 NHS Directors of Pharmacy of health board geographical areas in Scotland. 
They were invited to express interest in participation and to also identify and 
forward the email to other key individuals in their organisation responsible for 
either non-medical prescribing, medicines related policy developments or holding 
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senior positions within drug and therapeutics committees. Individuals expressing 
interest were sent a formal invitation, including study information and consent 
form.  
Questionnaire development 
The first round of data collection in the Delphi technique usually centres on 
synthesis of statements to be used in later rounds. This was not necessary for 
two reasons: a narrative review of the published and grey literature on service 
development and redesign identified issues to be considered; and the findings of 
qualitative, focus group research conducted by members of the research team 
with hospital based pharmacists throughout Scotland. These aimed to understand 
their perceptions on the implementation of pharmacist prescribing generally and 
specifically relating to antimicrobials [28]. Findings facilitated development of 
criteria, organised into two groupings of ‘service management’ and ‘pharmacist 
prescribing role specific’. These were presented as 30 statements with illustrative 
quotes obtained from previous qualitative work to provide contextualisation. An 
example is given in Box 1.  
Five point Likert scales were used to measure strength of agreement or 
disagreement (options of strongly agree/agree/unsure/disagree/strongly 
disagree), with space for free text comments and also providing experts the 
opportunity to suggest additional statements. The draft questionnaire was tested 
for face and content validity by four individuals experienced in pharmacy practice 
research, consensus methods, pharmacist prescribing education and training, and 
pharmacist prescribing practice. Minor changes were made to the questionnaire. 
Full study data collection and analysis 
One week prior to the Delphi link going live, an email alert was sent to the 
experts. Round one data collection commenced with the web-link to the 
questionnaire being emailed, with one email reminder sent seven days later. 
Anonymous, completed questionnaires were submitted to a university web 
address. Following completion of round one, data were analysed for achievement 
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of consensus. Definition of consensus has been noted to be 'one of the most 
contentious components of the [Delphi] method' [29]. Von der Gracht recently 
reviewed the measurement of consensus in Delphi studies since the emergence of 
the technique in the 1960s. The three most widely used and simplest measures 
are: subjective analysis by the researchers; average percent of majority opinions 
cut-off rate; and certain level of agreement [30]. The latter approach was 
adopted in this study, with consensus defined as 70% agreement (ranked 
strongly agree/agree) with each statement. Von der Gracht notes that the 
percentage is rather arbitrary but should represent the majority of respondents 
and usually exceeds 60%.  
Results were collated for each statement and fed back. The second round 
retained the same format as round one; at this stage, experts had the 
opportunity to reflect on and potentially revise their responses, but only for either 
those statements where the pre-set level of agreement had not been achieved or 
for new statements derived from round one comments. Based on the levels of 
agreement achieved, there was no need for a third round of data collection. 
 
RESULTS  
Of those 40 experts who returned consent forms, 35 (87.5%) responded to round 
one. Roles are described in Table 1, with some individuals having multiple roles.  
Experts were directors of hospital services, directors of pharmacy, chairmen of 
area drug and therapeutics committees, pharmacist prescribers, and 
pharmacist/non-pharmacist authors of local non-medical prescribing policies. 
Consensus in round one was achieved for 27/30 of statements, as shown in Table 
2. Very high levels of agreement (>90%) were achieved in areas of: objectively 
assessing the need for pharmacist prescribing, with focus on the potential for 
improved patient care and better use of resources; involving those pharmacists 
likely to be prescribing in discussions around planning and implementation; 
considering integrated care across the primary and secondary care interface; 
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defining and communicating the pharmacist prescribing role; clinical governance 
related activities; and supporting pharmacist prescribers in delivering their roles. 
The following comments were provided for those statements not achieving 
consensus.  
Statement - encourage the development of non-medical prescribing 
multidisciplinary teams 
Comments suggested that the emphasis of the statement should be altered to 
reflect the need for involvement of the wider healthcare team,  
‘non-medical prescribing should be based around a central multidisciplinary team, 
each member contributing. Extra teams would dilute, diffuse and potentially 
confuse lines of communication and I consider them unnecessary’. (pharmacist 
prescriber) 
‘would be dangerous as it appears to promote establishing a team to rival medical 
prescribers.  We must work with medics and develop consistent approaches and 
standards.’ (director of hospital services) 
Statement - encourage all hospital pharmacists to prescribe in any specialty 
Diverse comments were received reflecting divided opinions on those pharmacists 
to be trained as prescribers. Some viewed prescribing to be little change to the 
existing clinical role,  
‘clinical pharmacy involves giving prescribing advice to prescribers [physicians]. I 
consider pharmacist prescribing to be only a small step further since already the 
responsibility has been there but not 'signed for' directly.’ (pharmacist prescriber) 
‘prescribing is the future for all hospital pharmacist practitioners. There will be a 
period pre and post registration where prescribing should be strictly supervised 
but following a foundation training period all hospital pharmacists who have direct 
to patient pharmaceutical care responsibilities should prescribe.’ (director of 
hospital services) 
while others noted the need to target prescribing training based on experience, 
areas of practice, desires and patient need.   
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‘my indecision over ALL hospital pharmacists prescribing is due to (a) new 
entrants to hospital pharmacy from other sectors and (b) newly qualified 
pharmacists who will need mentoring before taking on this role.’ (director of 
hospital services, pharmacist prescriber, pharmacist author non-medical 
prescribing policy) 
‘pharmacist prescribing is not suitable for all areas of patient care. There are 
areas that are ideal, e.g. intensive care and clinics. In other words specialist 
areas.’ (pharmacist prescriber) 
‘I do not think it is something we should force upon pharmacists. Prescribers 
should want to prescribe, but I feel it opens up many doors and enhances their 
role within the multidisciplinary teams. It is part of my practice that I enjoy and 
get a great deal of job satisfaction with.’ (pharmacist prescriber) 
One noted the need for strategically planned service redesign,  
‘in my view pharmacists should only prescribe when a suitable service model 
exists and they have sufficient post registration training. A lot of our prescribing 
problems arise because most junior doctors learn prescribing on the job.’ 
(pharmacist prescriber, pharmacist author non-medical prescribing policy) 
 
 
Statement - ensure that pharmacist prescribers are financially compensated in 
line with their added responsibilities 
Opinion was divided between those favouring and those against remuneration, 
‘it is not legal or ethical to pay someone to prescribe. Pharmacists should see it as 
part of their expanded patient care role.’ (pharmacist prescriber) 
‘other non-medical prescribers, in particular nurses, are not financially 
compensated for this responsibility. Prescribing should be based on patient need 
not rewards.’ (non-pharmacist author non-medical prescribing policy) 
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‘In terms of financial remuneration - absolutely agree as at this level you are a 
clinician who happens to be a pharmacist rather than a pharmacist who 
prescribes.’ (pharmacist prescriber) 
In round two, participants were asked to rate agreement with two unchanged, 
one slightly altered and one new statement. Twenty-nine responses (72.5%) 
were received. Results are given in Table 3.  
 
DISCUSSION 
Key findings of this research are that high levels of consensus were obtained for 
almost all statements relating to aspects ‘service development’ and ‘pharmacist 
prescribing role development’. Issues of disagreement were around targeting of 
pharmacists and clinical specialities, and financial remuneration for prescribing in 
the hospital setting. 
This is the first published research to apply a consensus approach to aid strategic 
prescribing development and implementation within hospital. Strengths of this 
study are the involvement of expert opinion holders, the high levels of 
participation in both rounds of data collection and the development of consensus 
statements based on prior qualitative research.  
Findings should be interpreted with caution since data were collected in Scotland 
and hence may not be generalisable globally, particularly given the marked 
differences in healthcare structures and organisation. However, it is most likely 
that issues relating to aspects such as succession planning, multidisciplinary 
working, quality evaluation, outcome measures, education and future orientation 
of services will be relevant to other professional groupings, other countries and 
healthcare systems.  Reliance on the Directors of Pharmacy to identify experts 
may have introduced recruitment and response biases, particularly since those 
with negative views may not have been recruited.  
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While the high levels of consensus may indicate an element of acquiescence 
response bias and a potential lack of specificity, statements were grounded in 
both the published literature and prior qualitative work.  
Very high levels of agreement were achieved, largely in areas of service 
management, which have direct relevance to the principles of service redesign 
[17]. Emphasis was placed on objective pharmaceutical needs assessment 
relating to the needs of patients, the multidisciplinary team, the organisation and 
the profession. Similar levels of agreement were achieved for defining the role of 
the pharmacist prescriber and the scope of prescribing, effective communication, 
and developing and implementing the service within a clinical governance 
framework. This is very much in line with the stepped approach recommended as 
part of health needs assessment [31].  
Lack of agreement around the two issues of targeting pharmacists to train as 
prescribers and remuneration for prescribing are not surprising, and reflect the 
findings of others researching pharmacist prescribing implementation in the UK. 
These describe the underuse of skills following training as a prescriber, a lack of 
organisational recognition of the role of pharmacist prescriber, absence of any 
succession planning to ensure continuity of service and issues around funding 
[7,12,14]. There is therefore a clear need for a strategic and planned approach to 
service redesign which involves all key stakeholders and importantly not just 
those likely to express positive and supportive views. This is particularly the case 
if prescribing is to extend beyond those innovators most likely to take up the 
challenges and risks associated with change. Given the high levels of consensus 
obtained in this research, there is an opportunity to use the statements to 
develop a toolkit to assist service redesign around pharmacist prescribing within 
the hospital setting. Such a toolkit could be used in a strategic way and in 
advance of implementation of a new service such as prescribing.  
Interestingly, criteria that have been associated with role development in other 
areas of the nursing literature including research activity, leadership qualities and 
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consultancy [32], were not raised by expert members and may reflect the infancy 
of the pharmacist prescriber’s role in hospitals. However, these are key issues to 
ensure development of leadership skills and to focus on research evaluation to 
contribute to the emerging evidence base.   
Evaluation based research is warranted to determine the success of these 
consensus statements or toolkit in terms of utility, applicability, and how they 
impact service design, implementation and associated patient outcomes.  There is 
also potential to contextualise these statements for primary care pharmacist 
prescribing developments.  
CONCLUSION  
Consensus guidance has been developed, which could be used to inform service 
redesign around the implementation of pharmacist prescribing within hospital 
settings.   
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Box 1- an example of criterion, statement and illustrative quote relating to 
service redesign 
Criterion 
Service development, multidisciplinary working. 
 
Statement 
Involve all key members of the multidisciplinary team who are stakeholders when 
planning the strategy for pharmacist prescribing. 
 
Illustrative quote 
'…we shouldn’t just have that [regarding pharmacist roles] discussion with 
pharmacy; it should be held in a multidisciplinary setting, because we are very 
good in pharmacy to tell other folk what we think they should do, but we’re not 
very good at actually listening about what we should do, that would differ with 
different specialities and different hospitals, there will be different gaps, so you 
have to tailor to local circumstances.'  
18 
 
Table 1- description of expert panel member roles (n=35) (*some respondents 
had multiple roles hence >35)  
Role N* 
Director of pharmacy 4 
Director of hospital services  3 
Chairman of area drug and therapeutics committee  4 
Non-pharmacist author of local non-medical prescribing policy 5 
Pharmacist author of local non- medical prescribing policy 10 
Pharmacist prescriber 15 
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
                                                 
 Table 2 – Round one, percentage of respondents agreeing (strongly agree or agree) with Delphi statements (n=35) 
 
Criteria Statements  % strongly 
agree/agree 
Service Management   
 Succession Planning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Undertake a systematic and objective assessment of pharmaceutical 
needs in order to identify gaps in the current service delivery and patient 
care 
97 
- Outline ways in which prescribing may improve patient care or 
encourage better utilisation of staff skills and resources 
100 
- Have a strategy1 in place that is based on available national guidance 
and that would establish how prescribing is to be implemented 
94 
- Ensure that any strategy in place may be applicable across different 
practice settings and areas of care. This implies that the service is generic 
and transferable. 
77 
- Consider the benefits and limitations of both pharmacist supplementary 
and independent prescribing and determine which would be best suited to 
deliver the service in different areas of care. 
86 
- Involve pharmacists likely to be prescribing in planning discussions to 
ensure they have both sufficient background information to prescribing 
prior/prescribing course to implement prescribing.  
91 
- Consider in which practice settings it may be more feasible to introduce, 
implement and monitor prescribing. 
97 
- Consider procedures that would allow the smooth and safe transition of 
patients from secondary to primary care for prescribing.  
91 
 Multiprofessional 
Working 
- Involve all key members of the multidisciplinary team when planning the 
strategy for prescribing.  
97 
- Determine how likely it is for other key members of the multidisciplinary 
team to accept prescribing. 
89 
- Promote a good understanding of the prescribing role among other 
members of the multidisciplinary team. 
100 
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- Promote clearly defined roles for prescribing within the multidisciplinary 
team. 
94 
- Promote clearly defined lines of communication relating to prescribing for 
the multidisciplinary team. 
97 
- Encourage the development of non-medical prescribing multidisciplinary 
teams. 
66 
 Quality Evaluation - Establish that systems are in place (defined, documented and regularly 
reviewed) to promote patient safety and encourage quality patient care 
associated with prescribing in line with the ‘Clinical Governance 
Framework for Pharmacist Prescribers and Organisations Commissioning 
or Participating in Pharmacist Prescribing’ and any other local governance 
structures or strategies. 
97 
- Ensure that legal responsibilities and accountabilities are defined and 
documented within the strategy and have taken into account the 
“Professional Standards and Guidance for Pharmacist Prescribers” which 
are part of the Pharmacist Code of Ethics 
91 
 Practice Development - Consider any changes in current pharmacy service provision in 
secondary care that may be needed to support the development of a 
prescribing service. 
97 
- The strategy should include ways of assessing outcomes to measure any 
positive or negative impact of the role on other health care professionals. 
80 
 Outcome measures   
- The strategy should include ways of assessing outcomes to measure any 
positive or negative impact of the role on other health care professionals. 
80 
Pharmacist 
Prescribing Role 
Development 
  
 Education - Provide support for pharmacists during training or pharmacists who are 
planning to train to be prescribers. 
94 
- Provide clearly defined pharmacist competencies to help pharmacists 
achieve and maintain competency when prescribing (‘Maintaining 
Competency in Prescribing’, National Prescribing Centre). 
91 
- Clearly define the level and type of experience required to prescribe in 
different specialties. 
80 
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- Provide the necessary opportunities for education and training following 
qualification as a prescriber. 
97 
- Ensure that pharmacists are able to demonstrate competence on an on-
going basis to prescribe in their area of practice.  
94 
- Ensure that the preparation for the role has taken into consideration the 
pharmacists’ individual views and attitudes. 
70 
- Provide the necessary mentoring scheme to pharmacists who are 
prescribing. 
97 
 Future orientation of 
service 
- Encourage all hospital pharmacists to prescribe in any specialty.  
 
Consensus not 
reached (17% 
agree; 43% 
disagree) 
 
- Encourage the development of prescribing specialist roles. 
 
80 
- Ensure that pharmacist prescribers are financially compensated in line 
with their added responsibilities. 
Consensus not 
reached (60% 
agree; 11% 
disagree) 
 
23 
 
 Table 3 – Round two, percentage of respondents agreeing (strongly agree or agree) with Delphi statements (n=35) 
Statements  % strongly 
agree/agree 
- Unchanged from round one - encourage all hospital pharmacists to prescribe in any specialty.  
 
21 
- Unchanged from round one - ensure that pharmacist prescribers are financially compensated 
in line with their added responsibilities. 
 
55 
- Altered slightly from round one- encourage participation of pharmacist prescribers within 
multidisciplinary prescribing teams 
90 
- New  statement for round two- ensure that appropriate pharmacists are selected for the 
prescribing role by taking into consideration their individual views and attitudes towards 
pharmacist prescribing 
90 
 
